A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease

BACKGROUND: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthetase. Elevated ADMA reduces NO formation and is associated with endothelial dysfunction. The aims of this study were to evaluate endothelial function and the cardiovascular risk (CVR) pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayki Arslan, Muyesser, Turhan, Sibel, Dincer, Irem, Mizrak, Dilsa, Corapcioglu, Demet, Idilman, Ramazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424578/
https://www.ncbi.nlm.nih.gov/pubmed/25960770
http://dx.doi.org/10.1186/1758-5996-6-109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424578/
https://www.ncbi.nlm.nih.gov/pubmed/25960770
http://dx.doi.org/10.1186/1758-5996-6-109

Ejemplares similares